Detalles de la búsqueda
1.
Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop.
Endocr Pract
; 30(3): 282-291, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160940
2.
Coverage of education and training of traumatic brain injury-induced growth hormone deficiency in US residency and fellowship programs: a cross-sectional study.
BMC Med Educ
; 24(1): 53, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38200500
3.
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
Pituitary
; 26(1): 57-72, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36380045
4.
Quality of life after long-term biochemical control of acromegaly.
Pituitary
; 25(3): 531-539, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476257
5.
Oral Octreotide: A Review of Recent Clinical Trials and Practical Recommendations for Its Use in the Treatment of Patients With Acromegaly.
Endocr Pract
; 28(6): 637-645, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35452815
6.
American Association of Clinical Endocrinology Disease State Clinical Review: Evaluation and Management of Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Practical Case-Based Clinical Approach.
Endocr Pract
; 28(7): 719-731, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477029
7.
Effects of growth hormone receptor antagonism and somatostatin analog administration on quality of life in acromegaly.
Clin Endocrinol (Oxf)
; 94(1): 58-65, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779234
8.
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice.
Pituitary
; 24(5): 810-827, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34304361
9.
Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers.
Pituitary
; 24(4): 555-563, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33615399
10.
Osilodrostat: A Review of Recent Clinical Studies and Practical Recommendations for its Use in the Treatment of Cushing Disease.
Endocr Pract
; 27(9): 956-965, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389514
11.
Health Benefit Costs and Absenteeism Among Employed Patients With Acromegaly.
Endocr Pract
; 27(10): 1034-1039, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33940182
12.
Multidisciplinary management of acromegaly: A consensus.
Rev Endocr Metab Disord
; 21(4): 667-678, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914330
13.
Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic.
Endocr Pract
; 26(8): 915-922, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33471683
14.
OFF-LABEL USE AND MISUSE OF TESTOSTERONE, GROWTH HORMONE, THYROID HORMONE, AND ADRENAL SUPPLEMENTS: RISKS AND COSTS OF A GROWING PROBLEM.
Endocr Pract
; 26(3): 340-353, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32163313
15.
Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term real-world evidence study.
Pituitary
; 22(5): 542-551, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31440946
16.
Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers.
Pituitary
; 22(5): 514-519, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31401793
17.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Endocr Pract
; 25(11): 1191-1232, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31760824
18.
Pasireotide treatment does not modify hyperglycemic and corticosterone acute restraint stress responses in rats.
Stress
; 21(4): 370-375, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29661114
19.
A case series of atypical features of patients with biopsy-proven isolated IgG4-related hypophysitis and normal serum IgG4 levels.
Pituitary
; 21(3): 238-246, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29248982
20.
Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency.
Pituitary
; 19(1): 65-74, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26496767